These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
246 related articles for article (PubMed ID: 7902316)
1. Preneoplastic significance of hepatic iron-free foci in genetic hemochromatosis: a study of 185 patients. Deugnier YM; Charalambous P; Le Quilleuc D; Turlin B; Searle J; Brissot P; Powell LW; Halliday JW Hepatology; 1993 Dec; 18(6):1363-9. PubMed ID: 7902316 [TBL] [Abstract][Full Text] [Related]
2. Resistance to iron accumulation and presence of hepatitis B surface antigen in preneoplastic and neoplastic lesions in human hemochromatotic livers. Hirota N; Hamazaki M; Williams GM Hepatogastroenterology; 1982 Apr; 29(2):49-51. PubMed ID: 6282722 [TBL] [Abstract][Full Text] [Related]
3. The expression of transforming growth factor-alpha in cirrhosis, dysplastic nodules, and hepatocellular carcinoma: an immunohistochemical study of 70 cases. Yeh MM; Larson AM; Campbell JS; Fausto N; Rulyak SJ; Swanson PE Am J Surg Pathol; 2007 May; 31(5):681-9. PubMed ID: 17460450 [TBL] [Abstract][Full Text] [Related]
4. Magnetic resonance iron-free nodules in genetic hemochromatosis. Guyader D; Gandon Y; Sapey T; Turlin B; Mendler MH; Brissot P; Deugnier Y Am J Gastroenterol; 1999 Apr; 94(4):1083-6. PubMed ID: 10201487 [TBL] [Abstract][Full Text] [Related]
5. Liver transplantation to treat suspected hepatocellular carcinoma in iron-free foci in congenital hemochromatosis: case report. Quante M; Benckert C; Thelen A; Uhlmann D; Bartels M; Moche M; Dollinger M; Wittekind C; Jonas S Transplant Proc; 2011 Jun; 43(5):2066-9. PubMed ID: 21693327 [TBL] [Abstract][Full Text] [Related]
6. Iron-negative foci in siderotic macroregenerative nodules in human cirrhotic liver. A marker of incipient neoplastic lesions. Terada T; Nakanuma Y Arch Pathol Lab Med; 1989 Aug; 113(8):916-20. PubMed ID: 2757493 [TBL] [Abstract][Full Text] [Related]
7. [Premalignant lesions and hepatocellular carcinoma on non cirrhotic liver overloaded with iron]. Attia A; Blanc JF; Saric J; Balabaud C; Bioulac-Sage P Gastroenterol Clin Biol; 2000 Oct; 24(10):955-9. PubMed ID: 11084432 [TBL] [Abstract][Full Text] [Related]
8. HLA-linked hemochromatosis and other forms of iron overload. Bloom PD; Gordeuk VR; MacPhail AP Dermatol Clin; 1995 Jan; 13(1):57-63. PubMed ID: 7712651 [TBL] [Abstract][Full Text] [Related]
9. Increased liver iron stores in patients with hepatocellular carcinoma developed on a noncirrhotic liver. Turlin B; Juguet F; Moirand R; Le Quilleuc D; Loréal O; Campion JP; Launois B; Ramée MP; Brissot P; Deugnier Y Hepatology; 1995 Aug; 22(2):446-50. PubMed ID: 7635411 [TBL] [Abstract][Full Text] [Related]
10. Hepatocyte proliferative activity in chronic liver damage as assessed by the monoclonal antibody MIB1 Ki67 in archival material: the role of etiology, disease activity, iron, and lipid peroxidation. Farinati F; Cardin R; D'Errico A; De Maria N; Naccarato R; Cecchetto A; Grigioni W Hepatology; 1996 Jun; 23(6):1468-75. PubMed ID: 8675166 [TBL] [Abstract][Full Text] [Related]
12. Screening for hemochromatosis in asymptomatic subjects with or without a family history. Powell LW; Dixon JL; Ramm GA; Purdie DM; Lincoln DJ; Anderson GJ; Subramaniam VN; Hewett DG; Searle JW; Fletcher LM; Crawford DH; Rodgers H; Allen KJ; Cavanaugh JA; Bassett ML Arch Intern Med; 2006 Feb; 166(3):294-301. PubMed ID: 16476869 [TBL] [Abstract][Full Text] [Related]
13. Hepatic precancerous lesions and small hepatocellular carcinoma. Hytiroglou P; Park YN; Krinsky G; Theise ND Gastroenterol Clin North Am; 2007 Dec; 36(4):867-87, vii. PubMed ID: 17996795 [TBL] [Abstract][Full Text] [Related]
14. Liver cell dysplasia in liver cirrhosis and hepatocellular carcinoma. Szczepański W Pol J Pathol; 1997; 48(3):147-57. PubMed ID: 9401407 [TBL] [Abstract][Full Text] [Related]
15. Large cell change (liver cell dysplasia) and hepatocellular carcinoma in cirrhosis: matched case-control study, pathological analysis, and pathogenetic hypothesis. Lee RG; Tsamandas AC; Demetris AJ Hepatology; 1997 Dec; 26(6):1415-22. PubMed ID: 9397980 [TBL] [Abstract][Full Text] [Related]
16. Hepatic siderosis, fibrosis and cirrhosis: the association with hepatocellular carcinoma in high-risk population. Jaskiewicz K; Banach L; Lancaster E Anticancer Res; 1997; 17(5B):3897-9. PubMed ID: 9427800 [TBL] [Abstract][Full Text] [Related]
17. Macroregenerative nodules of the liver in primary biliary cirrhosis: report of two autopsy cases. Terada T; Kurumaya H; Nakanuma Y; Hayakawa Y; Matsuda H Am J Gastroenterol; 1989 Apr; 84(4):418-21. PubMed ID: 2539012 [TBL] [Abstract][Full Text] [Related]
18. Quantitative assessment of hTERT mRNA expression in dysplastic nodules of HBV-related hepatocarcinogenesis. Oh BK; Kim YJ; Park YN; Choi J; Kim KS; Park C Am J Gastroenterol; 2006 Apr; 101(4):831-8. PubMed ID: 16494581 [TBL] [Abstract][Full Text] [Related]
19. Liver iron excess in patients with hepatocellular carcinoma developed on non-alcoholic steato-hepatitis. Sorrentino P; D'Angelo S; Ferbo U; Micheli P; Bracigliano A; Vecchione R J Hepatol; 2009 Feb; 50(2):351-7. PubMed ID: 19070395 [TBL] [Abstract][Full Text] [Related]
20. Iron in the pathogenesis of hepatocellular carcinoma. Fargion S; Piperno A; Fracanzani AL; Cappellini MD; Romano R; Fiorelli G Ital J Gastroenterol; 1991 Dec; 23(9):584-8. PubMed ID: 1662094 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]